HomeBusinessHealthcare Industry Stock NewsOSTX CEO: 'We Have a Lot of Milestones Coming' in Tumor Research

OSTX CEO: 'We Have a Lot of Milestones Coming' in Tumor Research

Paul Romness, CEO of OS Therapies (OSTX), joins Nicole Petallides at the NYSE after the company recently completed a critical phase of its Osteosarcoma research. As OS Therapies readies to send its data to the FDA, Paul discusses the similarities of the disease between humans and dogs, and looks ahead to researching other solid tumors.

Trading 360

03 Oct 2024

SHARE

ON AIR
education
4:00 am
Your First Trade
replay
12:00 am
Trading 360
REPLAY
1:00 am
Fast Market
REPLAY
2:00 am
Next Gen Investing
REPLAY
3:00 am
Market Overtime
REPLAY
3:30 am
Market Overtime
REPLAY
ON AIR
education
4:00 am
Your First Trade
REPLAY
education
4:30 am
Inside the Mind of a Trader
REPLAY
education
5:00 am
Inside the Mind of a Trader
REPLAY
education
5:30 am
Inside the Mind of a Trader
REPLAY
6:00 am
Market Overtime
REPLAY
6:30 am
Market Overtime
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Trading 360
REPLAY
9:00 pm
Market Overtime
REPLAY
9:30 pm
Market Overtime
REPLAY
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor